Viewing Study NCT01455259


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-02-05 @ 11:05 AM
Study NCT ID: NCT01455259
Status: COMPLETED
Last Update Posted: 2016-02-17
First Post: 2011-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors
Sponsor: Uppsala University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AdCD40L View
None Adenoviral vector View
None CD40L View
None CD154 View
None malignant melanoma View